Neoadjuvant Chemotherapy with Reduced-Dose Carboplatin and Gemcitabine for Non-small Cell Lung Cancer in a Patient with Fanconi Anemia
- 1 April 2008
- journal article
- case report
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 3 (4), 447-450
- https://doi.org/10.1097/jto.0b013e318165c170
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Dose Escalating Study of Biweekly Gemcitabine and Carboplatin in Patients With Advanced CancerAmerican Journal of Clinical Oncology, 2007
- Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA RepairCell, 2007
- Evidence for subcomplexes in the Fanconi anemia pathwayBlood, 2006
- The interplay of Fanconi anemia proteins in the DNA damage responseDNA Repair, 2004
- Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCACancer Gene Therapy, 2004
- Vulvar cancer in a patient with Fanconi's anemia, treated with 3D conformal radiotherapyAmerican Journal of Hematology, 2004
- Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survivalOncogene, 2003
- Cancer in Fanconi anemia, 1927–2001Cancer, 2003
- Squamous cell carcinoma of the tongue in a patient with Fanconi's anemia: a case report and review of the literatureAnnals of Hematology, 2002
- Greffe de moelle dans l’anémie de Fanconi : à propos de sept casArchives de Pédiatrie, 2001